Today: 22 June 2026

Banks Warn of Bubble as AI Darling Palantir Plunges from Record High

Banks Warn of Bubble as AI Darling Palantir Plunges from Record High

Palantir shares fell about 7% Tuesday despite strong results, as analysts questioned its 246× forward earnings valuation after a 400% rally. Morgan Stanley and Goldman Sachs CEOs warned of a possible market pullback, citing stretched tech valuations. Major indexes slipped from record highs as Nvidia, Alphabet, and Amazon declined. Investors await more tech earnings and face uncertainty from a possible government shutdown and split Fed outlook.
4 November 2025
··
Pfizer’s Q3 Shocker: Earnings Beat, Outlook Raised, and a $7 Billion Obesity Drug Gambit

Pfizer’s Q3 Shocker: Earnings Beat, Outlook Raised, and a $7 Billion Obesity Drug Gambit

Pfizer reported Q3 2025 adjusted earnings of $0.87 per share, beating estimates, with revenue at $16.65–$16.7 billion. The company raised its full-year profit outlook to $3.00–$3.15 EPS. Sales of COVID products plunged, but demand for Eliquis and Vyndaqel rose. Pfizer sued Novo Nordisk over a $7.3 billion bid for obesity drugmaker Metsera; a court hearing is set for Nov. 4.
4 November 2025
···
Halliburton’s Big Comeback? Why Experts Say Oil Services Are ‘Down But Not Out’ in 2025

Halliburton’s Big Comeback? Why Experts Say Oil Services Are ‘Down But Not Out’ in 2025

Rothschild & Co Redburn initiated Halliburton with a Buy rating and $35 target, joining several firms raising price targets after strong Q3 results. Halliburton posted $5.6 billion in Q3 revenue, beating estimates, and is targeting $100 million in quarterly cost cuts. The company is expanding into data center power and automation amid weak U.S. shale spending. Shares trade near $27 as analysts forecast sector recovery by 2027.
4 November 2025
··
Shopify Q3 2025 Earnings: 32% Sales Surge, Bold Holiday Forecast – Is This Growth Stock Unstoppable?

Shopify Q3 2025 Earnings: 32% Sales Surge, Bold Holiday Forecast – Is This Growth Stock Unstoppable?

Shopify reported Q3 2025 revenue of $2.84 billion, up 32% year-over-year and above analyst estimates. Gross merchandise volume reached $92 billion, also rising 32%. Operating income climbed to $343 million, while free cash flow hit $507 million with an 18% margin. Shares fell about 3–4% pre-market after results, trading near $173 with a market cap over $220 billion.
4 November 2025
····
Grab Holdings (GRAB) Shocks with Q3 Beat & Forecast Hike – Stock Up 40% YTD, So Why the Post-Earnings Dip?

Grab Holdings (GRAB) Shocks with Q3 Beat & Forecast Hike – Stock Up 40% YTD, So Why the Post-Earnings Dip?

Grab shares fell about 9% to the mid-$5 range on Nov. 4, 2025, after Q3 earnings. Revenue rose 22% to $873 million, beating estimates, and net profit reached $17 million. The company raised its 2025 outlook, now guiding up to $3.40 billion in revenue. Monthly users climbed 14% to 47.7 million, with strong gains in food delivery and financial services.
4 November 2025
··
Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark shares plunged 14.6% on Nov. 3 to a 52-week low near $102 after announcing a $40 billion cash-and-stock deal to acquire Kenvue at a 46% premium. The drop erased about 15% of KMB’s market value, with the stock now down 21% year-over-year. Investors cited concerns over Kenvue’s litigation risks and debt load. KMB trades at 17.3× earnings, with a 4.9% dividend yield.
4 November 2025
··
New Fortress Energy Seeks U.K. Lifeline to Dodge Bankruptcy – Shares Crash as $9 B Debt Weighs

New Fortress Energy’s Wild Ride: 90% Crash, Debt Drama & a Surprise Rally – What’s Next for NFE Stock?

New Fortress Energy shares plunged over 90% year-to-date, closing at $1.18 on Nov. 3, before rebounding 32% in pre-market trading. The drop accelerated after reports of a UK debt restructuring plan to address $9 billion in liabilities and avoid U.S. bankruptcy. NFE faces “going concern” warnings ahead of Q3 earnings on Nov. 6, with analysts expecting another loss. The stock remains volatile amid contract wins and heavy downgrades.
4 November 2025
··
Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

Sarepta (SRPT) Stock Collapses 80% on FDA Bombshell – Is a Big Rebound Coming?

Sarepta Therapeutics shares plunged nearly 80% in 2025, falling from a high of $138.81 to around $15 after its Phase 3 ESSENCE trial failed and the FDA halted gene therapy trials following patient deaths. Q3 revenue beat estimates at $399.4 million, but the company posted a $179.9 million net loss. Sarepta restricted Elevidys sales to ambulatory patients after the FDA intervention. Analyst consensus is Hold, with a $34.50 average price target.
4 November 2025
··
PTL Limited (PTLE) Stock Soars on Surprise Profit Amid Delisting Risks – Key Facts & Outlook

PTL Limited (PTLE) Stock Soars on Surprise Profit Amid Delisting Risks – Key Facts & Outlook

PTL Limited (NASDAQ: PTLE) closed at $0.1861 on Nov 3, up 13%, then surged to $0.31 pre-market Nov 4 after reporting a surprise first-half profit of $1.21 million. The stock remains down about 97% year-to-date and faces Nasdaq delisting warnings. PTLE’s market cap stands near $7 million. Shares remain highly volatile, with a 52-week range of $0.14 to $15.78.
4 November 2025
·
Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s shares surged nearly 46% to $6.20 on Nov. 4, 2025, after announcing a $620 million go-private deal at $6.25 per share. The board approved the all-cash buyout by TriArtisan Capital, Treville Capital, and Yadav Enterprises, with closing expected by Q1 2026. Q3 revenue missed estimates at $113.2 million, and net income fell short at $0.6 million. Same-restaurant sales dropped 2.9% at Denny’s locations.
4 November 2025
···
UniQure’s Roller-Coaster: Gene Therapy Breakthrough, FDA Setback, and What’s Next for QURE Stock

UniQure Stock Plunges 50% on FDA Shocker – What’s Next for QURE’s Gene Therapy Ambitions?

uniQure shares plunged over 50% after the FDA said data for its Huntington’s disease gene therapy is not sufficient for approval, reversing earlier guidance. The stock dropped from about $68 to $34, wiping out roughly half its market value. Analysts called it a major regulatory setback, with some cutting price targets. Shareholder rights law firms launched investigations following the 57% one-day decline.
4 November 2025
·
Bitcoin Miner to AI Cloud Sensation: Why Iris Energy (IREN) Stock Is Soaring in 2025

From Bitcoin Miner to AI Cloud Powerhouse: Iris Energy’s Meteoric Rise (IREN Stock Soars on $9.7B Microsoft Deal)

Iris Energy (IREN) closed at $67.75 on Nov. 3, 2025, after announcing a $9.7 billion, five-year AI cloud contract with Microsoft, sending shares up 11.5%. The company’s market cap now tops $16.5 billion, up from $1 billion at the start of 2025. IREN posted FY2025 revenue of $501 million and net income of $86.9 million, driven by its pivot to AI cloud services and continued Bitcoin mining.
4 November 2025
···
Record 2026 Tax Refund Surge Looms as New Tax Cuts Fuel a $50 Billion “Stimulus”

Walmart Stock Soars on Tech & Holiday Buzz – Key Facts & Bold Predictions (Nov 2025 Update)

Walmart shares traded near $101.5 on November 4, close to a 52-week high and up 24% year-over-year. The company reported Q2 FY2026 net income of $7.2 billion, up 52%, and raised its full-year sales outlook. Walmart recently launched new AI shopping tools and partnered with Eli Lilly to offer discounted Zepbound. Wall Street remains bullish, with 31 of 32 analysts rating the stock a “Buy.”
4 November 2025
··
Lenskart IPO Frenzy: Sky-High Valuation Meets Surging Demand – Will Investors See Big Gains?

Lenskart IPO Frenzy: 7x Oversubscribed Amid Grey Market Jitters – Is Groww’s IPO the Safer Bet?

Lenskart’s ₹7,278 crore IPO was subscribed about 7 times, led by non-institutional bids at 10.2×. Shares list November 10, with grey market premiums cooling to ~14% above the ₹402 issue price. The IPO values Lenskart near ₹70,000 crore, or ~235× FY25 earnings, sparking debate over rich pricing. Brokerages mostly recommend subscribing, but some experts warn of stretched valuations and possible correction.
4 November 2025
Nasdaq Stumbles as Fed Jitters Mount, Intel Soars, Tariffs Rattle Tech Markets

AI Rally Hits Speed Bump as Futures Fall – Key Facts Before the Nov. 4 Market Open

U.S. stock futures fell sharply early Tuesday, with Nasdaq 100 futures down 1.2% and S&P 500 off 0.9%. The drop follows a stalled tech rally and overnight losses in Europe and Asia. Key economic data releases are delayed by a government shutdown, adding to market uncertainty. Palantir shares slid over 4% despite strong earnings, while Bitcoin dropped 3% to around $104,000.
4 November 2025
···········
IREN Stock Today (Sept 26, 2025): AI Cloud Moonshot Meets Wall Street Reality Check—Is the Rally Just Pausing or Running Out of Fuel?

Iren S.p.A. Stock Soars in 2025 Rally – Analysts Pump the Brakes Ahead of Big Strategic Reveal

Iren S.p.A. shares traded near €2.56 in early November 2025, up over 30% since January and close to their year-to-date high. The stock dipped 6–8% in late October after analysts at Kepler Cheuvreux and Equita SIM downgraded it to “Hold” ahead of quarterly results. First-half 2025 revenue rose 29% to €3.486 billion, with net profit up 24% to €184 million. Iren’s 2025 dividend reached €0.128 per share.
4 November 2025
·
Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Indian Stock Market Plunges! Sensex Crashes 500 Points, ₹2 Lakh Crore Lost – Here’s Why

The BSE Sensex dropped 519 points to 83,459 and the NSE Nifty 50 fell 166 points to 25,597, erasing recent gains and pushing Nifty below 25,600 for the first time in weeks. Investors lost over ₹2 lakh crore in market value as nearly all sectors declined. Weak global markets and continued foreign investor outflows weighed on sentiment. Dow Jones futures and major European and Asian indices also traded sharply lower.
4 November 2025
1 … 1,827 1,828 1,829 1,830 1,831 … 2,092

Stock Market Today

  • ASX Top Gainers and Losers June 26, 2022
    June 22, 2026, 5:09 AM EDT. The ASX300 saw notable volatility on June 26, with Ora Banda Mining leading winners, rising 6.58%, followed by Minerals 260 adding 5.91%. Other top gainers included Fletcher Building and Perenti, each up around 4.8-4.9%. On the downside, WiseTech Global plunged 18.44%, the steepest drop on the day. EQT Holdings also declined sharply by 11.56%. Other significant losers included Healius (-8.54%), IDP Education (-8.2%), and Tuas Limited (-7.42%). The ranking excludes low liquidity stocks, focusing on active trades. This daily report provides a snapshot of the largest percentage moves to inform market watchers of short-term ASX stock performance.

Latest articles

Fiji Tourism Surge Faces Sharper Question: Who Gains From the Money?

Fiji Tourism Surge Faces Sharper Question: Who Gains From the Money?

22 June 2026
Fiji Airways cabin crew now earn FJ$3,000–FJ$4,500 a month—about 2.6 times Fiji’s minimum wage—according to Aviation A2Z’s 2026 pay guide, spotlighting the airline’s wage premium as tourism arrivals hit 85,405 in May; however, Fiji Airways’ careers portal showed no active vacancies, limiting immediate investor impact.
Veterans Kick Off Indiana Freedom Runs Before America’s 250th

SPCX Faces Pressure With SpaceX’s $60 Billion AI Push Straining Valuation

22 June 2026
SpaceX (NASDAQ: SPCX) trades at $185, 37% above its $135 IPO price but down 18% from its $225.64 high, as profit-taking and debate over the $60 billion Cursor/Anysphere acquisition pressure shares; at this price, every $10 move shifts market value by about $131 billion, making upcoming research, index flows, and launch events critical for stock direction.
Go toTop